{"url_path":"/sec/ovid/proxy/2026-04-27/000162828026027624","section_key":"body","section_title":"DEFA14A body","topic":"sec","document":{"doc_type":"DEFA14A","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1636651/0001628280-26-027624-index.html","accession_number":"0001628280-26-027624","cik":"0001636651","ticker":"OVID","issuer_name":"Ovid Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1636651/0001628280-26-027624-index.html","primary_entity_key":"0001636651","primary_entity_name":"Ovid Therapeutics Inc."},"word_count":129,"has_tables":true,"body_markdown":"ovid-20260427\nDEFA14AFALSE000163665100016366512024-01-012024-12-31\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n______________________________________________________\n\nSCHEDULE 14A\n\nProxy Statement Pursuant to Section 14(a) of the\n\nSecurities Exchange Act of 1934\n\n(Amendment No.   )\n\n______________________________________________________\n\nFiled by the Registrant ☒\n\nFiled by a party other than the Registrant ☐\n\nCheck the appropriate box:\n\n☐Preliminary Proxy Statement\n\n☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))\n\n☐Definitive Proxy Statement\n\n☒Definitive Additional Materials\n\n☐Soliciting Material Pursuant to §240.14a-12\n\nOvid Therapeutics Inc.\n\n(Name of Registrant as Specified In Its Charter)\n\n(Name of Person(s) Filing Proxy Statement, if Other Than The Registrant)\n\nPayment of Filing Fee (Check the appropriate box):\n\n☒No fee required.\n\n☐Fee paid previously with preliminary materials.\n\n☐Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11."}